key: cord-1049739-o5g0rx3r
authors: Shen, Angela K.; Tan, Andy SL.
title: Trust, Influence and Community: Why pharmacists and pharmacies are central for addressing vaccine hesitancy
date: 2021-10-08
journal: J Am Pharm Assoc (2003)
DOI: 10.1016/j.japh.2021.10.001
sha: ac0ced2b94f08a4876504a1cefb4fe0b91f23250
doc_id: 1049739
cord_uid: o5g0rx3r

In 2019, the World Health Organization listed vaccine hesitancy, defined as the reluctance or refusal to vaccinate against preventable infectious diseases, as one of the top ten threats to global health. To address hesitancy, we must focus our attention on building vaccine confidence, trust in the vaccine itself, in providers who administer vaccines, and in the process that leads to vaccine licensure and the recommended vaccination schedule. Building vaccine confidence, particularly in communities who have higher levels of distrust of vaccines and low vaccination coverage rates is a critical public health priority, particularly in the current climate as the United States and the global public health community grapple with the COVID-19 pandemic. In this commentary, we focus on the central role pharmacists play in promoting the health and wellness of the local communities they are embedded in, how they are one of the most trusted sources for their communities when it comes to health information and care, and their unique position in making a significant contribution to building vaccine confidence. We propose to arm all health care professionals with a tool, the ASPIRE framework, which serves as a series of actionable steps to facilitate conversations with communities. This framework is intended to assist pharmacists in communicating with community members who may have concerns about vaccines by sharing trustworthy health information about vaccines to increase vaccine adoption. We conclude that it is insufficient to merely relay accurate health information about vaccines to the public and expect dramatic increases to vaccination rates. Accurate health information needs to be conveyed by trusted sources. Open engagement and dialogue layered on top of fundamental facts and messages are central to building confidence. Pharmacists and other providers can use tools, such as ASPIRE, to guide their conversations with community members to increase vaccine adoption.

In 2019, the World Health Organization listed vaccine hesitancy, defined as the reluctance or refusal to 2 vaccinate against preventable infectious diseases, as one of the top ten threats to global health. To 3 address hesitancy, we must focus our attention on building vaccine confidence, trust in the vaccine 4 itself, in providers who administer vaccines, and in the process that leads to vaccine licensure and the 5 recommended vaccination schedule. Building vaccine confidence, particularly in communities who have 6 higher levels of distrust of vaccines and low vaccination coverage rates is a critical public health priority, 7

particularly in the current climate as the United States and the global public health community grapple 8

with the COVID-19 pandemic. In this commentary, we focus on the central role pharmacists play in 9

promoting the health and wellness of the local communities they are embedded in, how they are one of 10 the most trusted sources for their communities when it comes to health information and care, and their 11 unique position in making a significant contribution to building vaccine confidence. We propose to arm 12 all health care professionals with a tool, the ASPIRE framework, which serves as a series of actionable 13 steps to facilitate conversations with communities. Pharmacists play a central role in promoting the health and wellness of the local communities they are 26 embedded in. Pharmacies are an integral part of communities across the nation, particularly in rural 27 areas of the United States 1 and pharmacists are one of the most trusted sources for their communities 28

when it comes to health information, health care, addressing vaccine concerns, answering questions, 29 correcting misinformation, and strongly recommending vaccination. 2-5 Since the H1N1 influenza 30 pandemic over a decade ago, pharmacists and pharmacies are increasingly integrated to deliver 31 vaccinations. 6 Prior to the H1N1 response, unlike hospitals and other health care facilities, many 32 pharmacies did not have partnerships with public health. The H1N1 response changed this and moved 33 public health officials to seek new partnerships. Pharmacies answered the call, offering convenience, 34 accessibility, extended hours of operation, and health care professionals who are licensed to vaccinate. Vaccine confidence is defined as trust in the vaccine itself, in providers who administer vaccines, and in 43 the process that leads to vaccine licensure and the recommended vaccination schedule. Building 44 confidence requires a collective effort from all healthcare providers that engage with patients and 45

communities. Pharmacists' confidence in these areas and their ability to communicate effectively to the 46 community is a key factor to building vaccine confidence. 8 Pharmacists are often viewed as trusted 47 sources of health information. 5 As a trusted source, they are key actors involved in establishing, 48 maintaining and building confidence in vaccines because their credibility (expertise, trustworthiness, 49 caring) can influence whether individuals accept health advice. 9-11 It is important to equip trusted 50 sources with the information and resources they need to engage in vaccine conversations. Trust, 51 attitudes and beliefs, healthcare provider confidence and the information environment on vaccines are 52 key factors that influence vaccine confidence. 8 53

Toward this end, we offer a framework, ASPIRE, for pharmacists to effectively engage in vaccine 55 conversations with their patients (Figure 1 ). Pharmacists can: 56  ASSUME people want to get vaccinated and be prepared for questions; 57 

Serving the Greater Good: Public Health & 149 Community Pharmacy Partnerships

Provider Status for Pharmacists: It's About Time

Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic 165

The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series

The availability 168 of pharmacies in the United States

Assessing the State of Vaccine Confidence in the United States: Recommendations from the National 170

Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on

Goodwill: A reexamination of the construct and its 174 measurement

The persuasiveness of source credibility: A critical review of five 176 decades' evidence

The Impact of Health Information Exposure 178 and Source Credibility on COVID-19 Vaccination Intention in Germany

COVID-19 Vaccines for Moderately to Severely Immunocompromised People

How to end the confusion of COVID-19 vaccine appointment scheduling

Walgreens offers $25 with COVID-19 vaccination

Pharmacies see continued growth as primary care hubs

Best practice guidance: How to respond to vocal vaccine deniers in public

COVID-19 vaccine hesitancy: 10 tips for talking with patients

Developing Covid-19 Vaccines at Pandemic Speed. N 229

230 31. WHO. Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process

Trusted Messengers and Trusted 234 Messages: The Role for Community-Based Organizations in Promoting COVID-19 and Routine 235 Immunizations

Trust in Science Is Not the Problem